ConductScience.org, home

Trial · NCT05119400

COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes

NCT05119400, Terminated, Weill Medical College of Cornell University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes. Trials, record NCT05119400. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05119400

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes
NCT number
NCT05119400
Status
Terminated
Enrollment
2 participants, actual
Lead sponsor
Weill Medical College of Cornell University
Conditions
Covid19, Anxiety, Mood, Cognitive Impairment
First posted
2021-11-15
Last updated
2024-04-12

Source ClinicalTrials.gov

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCognitive functioning as measured by Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (English)Once, 6 months to 36 months post-discharge from the hospital.
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) comprises auditory and visual subtasks of attention, language, visuospatial/constructional abilities, and immediate and delayed memory. Each subtask is assessed as accuracy (number of correct responses) and subsequently combined into a composite score (RBANS Total Scale score).
SecondaryExecutive functioning as measured by the Oral Trail Making Test-B (OTMT-B; English)Once, 6 months to 36 months post-discharge from the hospital.
The oral version of the Trail Making Test (OTMT) assesses processing speed, working memory, and attention. Participants have to say out loud numbers and letters in alternating sequence and the time to completion is recorded.
SecondaryCognitive control as measured by the Stroop test (English)Once, 6 months to 36 months post-discharge from the hospital.
The Stroop Color and Word Test (SCWT) is used to assess verbal processing speed and ability to inhibit cognitive interference. Participants have to read out loud words, colors, and color words printed in different colored ink. The number of correct responses in 45 seconds is recorded.
SecondaryVerbal intellectual ability as measured by the National Adult Reading Test (NART) for English speakers and the Word Accentuation Test (WAT).Once, 6 months to 36 months post-discharge from the hospital.Participants have to read a set of words out loud and the number correct is recorded. Number of errors are recorded out of 61 words.
SecondaryVerbal Fluency (English)Once, 6 months to 36 months post-discharge from the hospital.
This test requires participants to verbally produce words that start with given letters in a given time. The number of total valid words is used to indicate of successful selective information retrieval from memory.
SecondaryMood symptoms as assessed by DASS (English)Once, 6 months to 36 months post-discharge from the hospital.
Participants' moods will be assessed by Depression and Anxiety Scale (DASS) which is 42 item quantitative measure of three related negative emotional states of depression, anxiety and stress. The scores are interpreted for all three areas and higher scores indicate that the participant experiences increased emotional distress in either or all areas. For depression, the score ranges of 0-9 mean normal, 10-13 is mild, 14-20 moderate, 21-27 severe, and 28+ would be categorized under extremely severe depression. For anxiety, 0-7 is normal, 8-9 mild, 10-14 moderate, 15-19 severe, 20+ extremely severe. And for Stress, 0-14 is normal, 15-18 mild, 19-25 moderate, 26-33 severe, and 34+ extremely severe.
SecondaryMood symptoms as assessed by PANAS (English)Once, 6 months to 36 months post-discharge from the hospital.
The Positive and Negative Affect Schedule (PANAS) is a 20-item scale to measure affect. The scale consists of different words that alternate between positive and negative affect and each item is rated on a 5 point scale. Scores can range from 10-50 for both the Positive and Negative Affect with the lower scores representing lower levels of Positive/Negative Affect and higher scores representing higher levels of Positive/Negative Affect.
SecondaryAcceptance as assessed by AAQ-II (English)Once, 6 months to 36 months post-discharge from the hospital.
The Acceptance and Action Questionnaire (AAQ) is a 7-item self-report questionnaire used to measure psychological inflexibility and experiential avoidance. Scores range from 7- 49 with higher scores indicating higher level of inflexibility/avoidance.
SecondaryResilience as assessed by Brief Resilience Scale (English)Once, 6 months to 36 months post-discharge from the hospital.
The Brief Resilience Scale (BRS) is 6-item questionnaire used to assess the participant's perceived ability to recover from stressful events. The possible score range on each item is from 1 (low resilience) to 5 (high resilience).
SecondaryCognitive difficulties in daily life as assessed by Neuro Quality of Life (NeuroQOL) (English)Once, 6 months to 36 months post-discharge from the hospital.
NeuroQOL is a self-report questionnaires used to determine cognitive difficulties in participants' tasks of daily living. Scores range from 8-40 where lower score indicate that the participant experiences cognitive difficulties in their daily tasks and higher scores indicate minimum or no cognitive difficulties.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests5

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Attention Network TestSecondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition
Trail Making Test ASecondary outcomeConductCognition
Trail Making Test BSecondary outcomeConductCognition
Verbal FluencySecondary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05119400

GET https://conductscience.org/api/trials/v1/NCT05119400/registered